"He opens people's eyes to the possibilities of what a pharmacist can do," a University of Washington student says about clinical professor Don Downing.
The decision by the drugmaker Gilead Science, Inc. to charge $84,000 for a 12-week course of its new hepatitis C drug Sovaldi (sofosbuvir) has churned up protest.
A new drug, pritelivir, may offer a new treatment option for patients with genital herpes, a study led by University of Washington researchers has found. The study appears in this week’s New England Journal of Medicine.
Faculty members from the UW School of Pharmacy and the UW School of Medicine have secured a $4.7 million National Institutes of Health grant to study drug disposition during pregnancy.
Physicians ordered or provided 2.8 billion drugs for their patients in 2013, and those numbers have risen steadily, according to the Centers for Disease Control and Prevention (CDC). More people than ever are taking prescription drugs.
